Oxytocin use during D&C for early miscarriage
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether giving oxytocin during a dilation and curettage (D&C) procedure for a first-trimester miscarriage helps reduce bleeding and other complications. Oxytocin is a medicine that helps the uterus contract, which may make the procedure safer and more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 11 and a half weeks pregnant and have had a missed miscarriage
- You are 18 years old or older and can give your own consent
- You are not allergic to oxytocin
- You do not have any unusual shape of the uterus (like a divided uterus)
- You do not have fibroids (non-cancerous growths in the uterus)
- You do not have a bleeding or clotting disorder, or heart disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of taking medicine (by mouth or vaginal insertion) to safely manage a miscarriage that was discovered on ultrasound between 8–16 weeks of pregnancy. The goal is to see which method works better and causes fewer side effects.
This study compares different treatment methods for early missed abortion (when a pregnancy ends but the tissue doesn't pass on its own) to see which works best in real-world settings. It may help you and your doctor choose the safest and most effective option.
This trial tests if giving oxytocin before a dilation and evacuation (D&E) procedure helps reduce bleeding. It may help people scheduled for a D&E at 18 weeks or later.
This study looks at how oxytocin (a medicine often used to help with labor and uterine contractions) moves through the body and what it does during a non-emergency C-section. It may help improve how oxytocin is used in the future for safer, more predictable delivery care.
This trial tests whether taking an aromatase inhibitor (letrozole) before misoprostol helps complete a miscarriage more effectively. It may offer a treatment option for people with a missed or early pregnancy loss.
This trial tests whether adding letrozole (a hormone pill) to misoprostol (a medicine to complete a miscarriage) works better than misoprostol alone for ending a missed miscarriage in early pregnancy. It aims to make the process safer and possibly faster.
Hear when a new Missed Abortion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.